NORTH AMERICA LIQUID BIOPSY MARKET 2019-2027

Lifesciences | Diagnostic & Biotechnology

NORTH AMERICA LIQUID BIOPSY MARKET 2019-2027

Market By Therapeutic Application, Product, Analysis Purpose, End-user, Analysis Platform, Biomarker Type, Clinical Application And Geography | Forecast 2019-2027

Request Free Sample

Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

Triton Market Research has concluded that the North America liquid biopsy market is projected to grow at a CAGR of 20.25% in the estimated years 2019-2027.

The countries that have been studied in the North America liquid biopsy market are:

•           The United States

•           Canada

Cancer has adversely affected the lives of people across the world. This fact particularly holds true for the United States, as it is one of the countries with the highest rates of cancer, globally. It ranks at number 7 and estimates suggest that approximately 450 of every 100,000 residents in the US will develop cancer annually. Cancer not only causes trauma to the patients & their families, but also burdens the healthcare system. The national expenditure for cancer reached $125 billion in the year 2010, and is expected to reach $156 billion by 2020.

Report scope can be customized per your requirements. Request For Customization

The eastern side of the US is reported to have the highest cancer rates. With 511.7 people out of 100,000 developing the disease every year, Kentucky has the highest cancer incidence. Owing to the poor economic condition in the state, it has not adequately invested in cancer prevention & detection; therefore, Kentucky also has the highest rate of cancer deaths. Kentucky lays its foundation on the tobacco industry, a legacy that remains today, as nearly a fourth of its population smokes cigarettes. This habit of smoking explains the high prevalence of lung cancer here than in any other state in the nation.

Bio-Rad Laboratories, Inc. is a United States-based specialty chemical company that manufactures its products for pharmaceutical, biochemical and other life sciences research applications. It provides a wide range of test kits, informatics systems, test systems, laboratory instruments, apparatus, reagents and specialized quality controls. Bio-Rad provides these products to food producers, researchers, biotechnology, pharmaceutical manufacturers, government agencies, industrial research organizations, universities, clinical laboratories and hospitals. The company holds an experienced business unit with more than 59 years in the speciality chemicals segment.


Related Reports

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027
Lifesciences

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027

Market By Type, Application, E ..

VIEW REPORT
ASIA PACIFIC BIOCHIPS MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOCHIPS MARKET 2019-2027

Market By Type, Substrate Mate ..

VIEW REPORT
ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027

Market By Device Type, Therape ..

VIEW REPORT
ASIA PACIFIC DNA VACCINES MARKET 2019-2027
Lifesciences

ASIA PACIFIC DNA VACCINES MARKET 2019-2027

Market By Type, Application, T ..

VIEW REPORT
ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027
Lifesciences

ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027

Market By Technology, Applicat ..

VIEW REPORT
ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028
Lifesciences

ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028

Market By Application, Type, E ..

VIEW REPORT

Table of Content

1.    NORTH AMERICA LIQUID BIOPSY MARKET - SUMMARY

2.    INDUSTRY OUTLOOK

2.1. MARKET DEFINITION

2.2. KEY INSIGHT

2.3. PORTER’S FIVE FORCES ANALYSIS

2.3.1.   THREAT OF NEW ENTRANTS

2.3.2.   THREAT OF SUBSTITUTES

2.3.3.   BARGAINING POWER OF BUYERS

2.3.4.   BARGAINING POWER OF SUPPLIERS

2.3.5.   THREAT OF RIVALRY

2.4. REGULATORY FRAMEWORK

2.5. KEY MARKET TRENDS

2.6. KEY LIQUID BIOPSY INITIATIVES

2.7. MARKET ATTRACTIVENESS INDEX

2.8. MARKET DRIVERS

2.8.1.   CANCER CASES IN OLDER POPULACE ARE SIGNIFICANTLY INCREASING

2.8.2.   DIAGNOSTIC CENTERS ARE IN DEMAND

2.8.3.   TISSUE/TUMOR-AGNOSTIC DRUGS USAGE ARE INCREASING

2.8.4.   RISE IN USAGE OF PRECISION MEDICINE

2.9. MARKET RESTRAINTS

2.9.1.   HIGH COST OF TEST

2.9.2.   LACK OF A CONSENSUS ON STANDARD OPERATING PROCEDURES (SOPs)

2.10.            MARKET OPPORTUNITIES

2.10.1.                ADVANCEMENT IN TECHNOLOGY

2.10.2.                RISING NUMBER OF CANCER PATIENTS

2.11.            MARKET CHALLENGES

2.11.1.                LACK OF REIMBURSEMENT

2.11.2.                SKILLED PROFESSIONALS ARE QUITE LESS IN NUMBERS

3.    LIQUID BIOPSY MARKET OUTLOOK - BY THERAPEUTIC APPLICATION

3.1. PROSTATE CANCER

3.2. MELANOMA CANCER

3.3. BREAST CANCER

3.4. COLORECTAL CANCER

3.5. LUNG CANCER

3.6. OTHER TYPES OF CANCER

3.7. NON-ONCOLOGY APPLICATIONS

4.    LIQUID BIOPSY MARKET OUTLOOK - BY PRODUCT

4.1. CELL-FREE DNA (CFDNA)

4.2. CIRCULATING TUMOR CELLS (CTCS)

4.3. CIRCULATING TUMOR DNA (CTDNA)

4.4. EXTRACELLULAR VESICLES AND OTHERS

5.    LIQUID BIOPSY MARKET OUTLOOK - BY ANALYSIS PURPOSE

5.1. MONITORING

5.2. THERAPY GUIDANCE

5.3. EARLY DETECTION/SCREENING

5.4. DIAGNOSIS

6.    LIQUID BIOPSY INDUSTRY OUTLOOK - BY END-USER

6.1. HOSPITALS

6.2. PHYSICIANS’ OFFICE LABORATORIES

6.3. CLINICAL DIAGNOSTIC LABORATORIES

7.    LIQUID BIOPSY MARKET OUTLOOK - BY ANALYSIS PLATFORM

7.1. MICROARRAY

7.2. NGS

7.3. PROTEOMICS

7.4. PCR

7.5. OTHER ANALYSIS PLATFORMS

8.    LIQUID BIOPSY MARKET OUTLOOK - BY BIOMARKER TYPE

8.1. NUCLEIC ACIDS

8.2. PROTEINS

8.3. EXTRACELLULAR VESICLES

8.4. CELLS

9.    LIQUID BIOPSY MARKET OUTLOOK - BY CLINICAL APPLICATION

9.1. TREATMENT MONITORING

9.2. PROGNOSIS & REOCCURRENCE MONITORING

9.3. TREATMENT SELECTION

9.4. DIAGNOSIS & SCREENING

10. LIQUID BIOPSY MARKET - REGIONAL OUTLOOK

10.1.            NORTH AMERICA

10.2.            COUNTRY ANALYSIS

10.2.1.1.   THE UNITED STATES

10.2.1.2.   CANADA

11. COMPETITIVE LANDSCAPE

11.1.            AGILENT TECHNOLOGIES, INC.

11.2.            BOSTON SCIENTIFIC CORPORATION

11.3.            ARGON MEDICAL DEVICES, INC.

11.4.            B. BRAUN MELSUNGEN AG

11.5.            CINTEC MEDICAL LTD.

11.6.            ROCHE DIAGNOSTICS CORPORATION

11.7.            AD-TECH MEDICAL INSTRUMENT CORP.

11.8.            I.M.S. INTERNAZIONALE MEDICO SCIENTIFICA SRL

11.9.            QIAGEN N.V.

11.10.         BECTON, DICKINSON

11.11.         PLANMECA OY

11.12.         BIO-RAD LABORATORIES, INC.

11.13.         CARDINAL HEALTH, INC.

11.14.         COOK MEDICA, INC.

11.15.         FISCHER MEDICAL TECHNOLOGIES LLC

11.16.         C. R. BARD, INC. (ACQUIRED BY BECTON, DICKINSON AND COMPANY)

12. RESEARCH METHODOLOGY & SCOPE

12.1.            RESEARCH SCOPE & DELIVERABLES

12.1.1.                OBJECTIVES OF STUDY

12.1.2.                SCOPE OF STUDY

12.2.            SOURCES OF DATA

12.2.1.                PRIMARY DATA SOURCES

12.2.2.                SECONDARY DATA SOURCES

12.3.            RESEARCH METHODOLOGY

12.3.1.                EVALUATION OF PROPOSED MARKET

12.3.2.                IDENTIFICATION OF DATA SOURCES

12.3.3.                ASSESSMENT OF MARKET DETERMINANTS

12.3.4.                DATA COLLECTION

12.3.5.                DATA VALIDATION & ANALYSIS

List of table

TABLE 1        NORTH AMERICA LIQUID BIOPSY MARKET 2019-2027 ($ MILLION)

TABLE 2        LIQUID BIOPSY BIOMARKER CLASSES

TABLE 3        NORTH AMERICA LIQUID BIOPSY MARKET BY THERAPEUTIC APPLICATION 2019-2027 ($ MILLION)

TABLE 4        NORTH AMERICA LIQUID BIOPSY MARKET BY PRODUCT 2019-2027 ($ MILLION)

TABLE 5        NORTH AMERICA LIQUID BIOPSY MARKET BY ANALYSIS PURPOSE 2019-2027 ($ MILLION)

TABLE 6        NORTH AMERICA LIQUID BIOPSY MARKET BY END-USER 2019-2027 ($ MILLION)

TABLE 7        NORTH AMERICA LIQUID BIOPSY MARKET BY ANALYSIS PLATFORM 2019-2027 ($ MILLION)

TABLE 8        ADVANTAGES OF DROPLET DIGITAL PCR FOR SINGLE-CELL ANALYSIS

TABLE 9        DROPLET DIGITAL PCR INDUSTRIES

TABLE 10      NORTH AMERICA LIQUID BIOPSY MARKET BY BIOMARKER TYPE 2019-2027 ($ MILLION)

TABLE 11      CELL DIFFERENTIATORS

TABLE 12      NORTH AMERICA LIQUID BIOPSY MARKET BY CLINICAL APPLICATION 2019-2027 ($ MILLION)

TABLE 13      NORTH AMERICA LIQUID BIOPSY MARKET BY COUNTRY 2019-2027 ($ MILLION)

List of Figures

FIGURE 1      NORTH AMERICA LIQUID BIOPSY MARKET 2019-2027 ($ MILLION)

FIGURE 2      NORTH AMERICA LIQUID BIOPSY MARKET BY PROSTATE CANCER 2019-2027 ($ MILLION)

FIGURE 3      NORTH AMERICA LIQUID BIOPSY MARKET BY MELANOMA CANCER 2019-2027 ($ MILLION)

FIGURE 4      TYPES OF BREAST CANCER

FIGURE 5      NORTH AMERICA LIQUID BIOPSY MARKET BY BREAST CANCER 2019-2027 ($ MILLION)

FIGURE 6      NORTH AMERICA LIQUID BIOPSY MARKET BY COLORECTAL CANCER 2019-2027 ($ MILLION)

FIGURE 7      NORTH AMERICA LIQUID BIOPSY MARKET BY LUNG CANCER 2019-2027 ($ MILLION)

FIGURE 8      NORTH AMERICA LIQUID BIOPSY MARKET BY OTHER TYPES OF CANCER 2019-2027 ($ MILLION)

FIGURE 9      NORTH AMERICA LIQUID BIOPSY MARKET BY NON-ONCOLOGY APPLICATION 2019-2027 ($ MILLION)

FIGURE 10   NORTH AMERICA LIQUID BIOPSY MARKET BY CELL-FREE DNA (CFDNA) 2019-2027 ($ MILLION)

FIGURE 11   NORTH AMERICA LIQUID BIOPSY MARKET BY CIRCULATING TUMOR CELLS (CTCS) 2019-2027 ($ MILLION)

FIGURE 12   NORTH AMERICA LIQUID BIOPSY MARKET BY CIRCULATING TUMOR DNA (CTDNA) 2019-2027 ($ MILLION)

FIGURE 13   NORTH AMERICA LIQUID BIOPSY MARKET BY EXTRACELLULAR VESICLES AND OTHERS 2019-2027 ($ MILLION)

FIGURE 14   NORTH AMERICA LIQUID BIOPSY MARKET BY MONITORING 2019-2027 ($ MILLION)

FIGURE 15   NORTH AMERICA LIQUID BIOPSY MARKET BY THERAPY GUIDANCE 2019-2027 ($ MILLION)

FIGURE 16   NORTH AMERICA LIQUID BIOPSY MARKET BY EARLY DETECTION/SCREENING 2019-2027 ($ MILLION)

FIGURE 17   NORTH AMERICA LIQUID BIOPSY MARKET BY DIAGNOSIS 2019-2027 ($ MILLION)

FIGURE 18   NORTH AMERICA LIQUID BIOPSY MARKET BY HOSPITALS 2019-2027 ($ MILLION)

FIGURE 19   NORTH AMERICA LIQUID BIOPSY MARKET BY PHYSICIANS’ OFFICE LABORATORIES 2019-2027 ($ MILLION)

FIGURE 20   NORTH AMERICA LIQUID BIOPSY MARKET BY CLINICAL DIAGNOSTIC LABORATORIES 2019-2027 ($ MILLION)

FIGURE 21   NORTH AMERICA LIQUID BIOPSY MARKET BY MICROARRAY 2019-2027 ($ MILLION)

FIGURE 22   NORTH AMERICA LIQUID BIOPSY MARKET BY NGS 2019-2027 ($ MILLION)

FIGURE 23   NORTH AMERICA LIQUID BIOPSY MARKET BY PROTEOMICS 2019-2027 ($ MILLION)

FIGURE 24   NORTH AMERICA LIQUID BIOPSY MARKET BY PCR 2019-2027 ($ MILLION)

FIGURE 25   NORTH AMERICA LIQUID BIOPSY MARKET BY OTHER ANALYSIS PLATFORM 2019-2027 ($ MILLION)

FIGURE 26   NORTH AMERICA LIQUID BIOPSY MARKET BY NUCLEIC ACIDS 2019-2027 ($ MILLION)

FIGURE 27   NORTH AMERICA LIQUID BIOPSY MARKET BY PROTEINS 2019-2027 ($ MILLION)

FIGURE 28   NORTH AMERICA LIQUID BIOPSY MARKET BY EXTRACELLULAR VESICLES 2019-2027 ($ MILLION)

FIGURE 29   NORTH AMERICA LIQUID BIOPSY MARKET BY CELLS 2019-2027 ($ MILLION)

FIGURE 30   NORTH AMERICA LIQUID BIOPSY MARKET BY TREATMENT MONITORING 2019-2027 ($ MILLION)

FIGURE 31   NORTH AMERICA LIQUID BIOPSY MARKET BY PROGNOSIS & REOCCURRENCE MONITORING 2019-2027 ($ MILLION)

FIGURE 32   NORTH AMERICA LIQUID BIOPSY MARKET BY TREATMENT SELECTION 2019-2027 ($ MILLION)

FIGURE 33   NORTH AMERICA LIQUID BIOPSY MARKET BY DIAGNOSIS & SCREENING 2019-2027 ($ MILLION)

FIGURE 34   NORTH AMERICA LIQUID BIOPSY MARKET 2019-2027 ($ MILLION)

FIGURE 35   THE UNITED STATES LIQUID BIOPSY MARKET 2019-2027 ($ MILLION)

FIGURE 36   NEW CANCER CASES & CANCER DEATHS IN THE US 2016-2020 (PER 100,000 PEOPLE)

FIGURE 37   CANADA LIQUID BIOPSY MARKET 2019-2027 ($ MILLION)

Purchase Options

  • Licence Type
  • Price
  • User/Sharing
  • Printing
  • Delivery Formats
  • Free customization (Pre-sale)
  • Analyst hour support (Post Sale)
  • Customized notification for newly published report
  • Free report on update (within 180 days)

Single User PDF

$1,500.00

  • User/Sharing
  • Restricted to one authorized user
  • Printing
  • Not printable
  • Delivery Formats
  • Pdf
  • Free customization (Pre-sale)
  • 10% Free customization
  • Analyst hour support (Post Sale)
  • 3 hours
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Enterprise Online/PDF

$2,200.00

  • User/Sharing
  • Unlimited
  • Printing
  • Unlimited
  • Delivery Formats
  • Pdf and market estimation excel
  • Free customization (Pre-sale)
  • 20% Free customization
  • Analyst hour support (Post Sale)
  • 8 hour
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Request free Sample

SUBMIT REQUEST
Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

;